News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,507 Results
Type
Article (87664)
Company Profile (824)
Press Release (777005)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233153)
Career Advice (4142)
Deals (39827)
Drug Delivery (143)
Drug Development (91323)
Employer Resources (203)
FDA (18328)
Job Trends (17412)
News (397618)
Policy (39939)
Tag
Academia (3006)
Academic (2)
Accelerated approval (22)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (157)
Alzheimer's disease (1730)
Antibody-drug conjugate (ADC) (285)
Approvals (18404)
Artificial intelligence (558)
Autoimmune disease (122)
Automation (32)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (180)
Biotechnology (487)
Bladder cancer (143)
Brain cancer (57)
Breast cancer (555)
Cancer (4425)
Cardiovascular disease (396)
Career advice (3564)
Career pathing (39)
CAR-T (267)
CDC (57)
Cell therapy (736)
Cervical cancer (34)
Clinical research (76181)
Collaboration (1528)
Company closure (4)
Compensation (1014)
Complete response letters (64)
COVID-19 (2969)
CRISPR (92)
C-suite (687)
Cystic fibrosis (145)
Data (5384)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (483)
Diagnostics (7140)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (261)
Drug pricing (203)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99851)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (134164)
Executive appointments (1005)
FDA (21056)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1384)
Gene editing (198)
Generative AI (56)
Gene therapy (599)
GLP-1 (1071)
Government (5409)
Grass and pollen (8)
Guidances (378)
Healthcare (20941)
HIV (54)
Huntington's disease (43)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (27)
Indications (68)
Infectious disease (3234)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (207)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (628)
Lymphoma (311)
Machine learning (35)
Management (66)
Manufacturing (710)
MASH (164)
Medical device (14947)
Medtech (14985)
Mergers & acquisitions (22842)
Metabolic disorders (1256)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (284)
Neuropsychiatric disorders (78)
Neuroscience (2877)
NextGen: Class of 2025 (7703)
Non-profit (5099)
Now hiring (60)
Obesity (598)
Opinion (322)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (191)
Parkinson's disease (261)
Partnered (33)
Patents (448)
Patient recruitment (367)
Peanut (58)
People (66515)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23497)
Phase II (33061)
Phase III (24928)
Pipeline (3520)
Policy (314)
Postmarket research (3554)
Preclinical (10623)
Press Release (72)
Prostate cancer (221)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (740)
Real estate (7432)
Recruiting (80)
Regulatory (28359)
Reports (65)
Research institute (2709)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (81)
Schizophrenia (144)
Series A (223)
Series B (169)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (43)
Startups (4322)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1081)
Venture capital (74)
Weight loss (421)
Women's health (72)
Worklife (21)
Date
Today (37)
Last 7 days (364)
Last 30 days (3248)
Last 365 days (33335)
2025 (31043)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (319)
Arkansas (14)
Asia (51192)
Australia (9002)
California (10501)
Canada (3092)
China (998)
Colorado (442)
Connecticut (474)
Delaware (303)
Europe (117762)
Florida (1535)
Georgia (340)
Hawaii (3)
Idaho (68)
Illinois (863)
India (60)
Indiana (506)
Iowa (21)
Japan (355)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1377)
Massachusetts (7797)
Michigan (332)
Minnesota (611)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (115)
New Hampshire (81)
New Jersey (2881)
New Mexico (32)
New York (2817)
North Carolina (1504)
North Dakota (10)
Northern California (4904)
Ohio (320)
Oklahoma (22)
Oregon (51)
Pennsylvania (2151)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (58)
South Dakota (1)
Southern California (4031)
Tennessee (162)
Texas (1642)
United States (38303)
Utah (316)
Vermont (1)
Virginia (268)
Washington D.C. (85)
Washington State (879)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,507 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Delivery
Lilly Cuts Zepbound Prices, Again, When Buying Through DTC Program
Following Novo Nordisk’s price cuts for its own GLP-1 medicines, Eli Lilly is offering discounts for the obesity drug purchased through LillyDirect. Both pharmas recently struck a deal with the White House for cheaper prices via the yet-to-be-launched TrumpRx.
December 1, 2025
·
1 min read
·
Dan Samorodnitsky
Series B
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the underlying biological cause of AL amyloidosis.
December 1, 2025
·
1 min read
·
Tristan Manalac
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
The centerpiece of the deal is the
in vivo
editor TSRA-196, which in preclinical studies has shown robust editing at SERPINA1, the locus linked to alpha-1 antitrypsin deficiency.
December 1, 2025
·
1 min read
·
Tristan Manalac
Vaccines
FDA’s Prasad Links 10 Child Deaths to COVID-19 Vaccines, Eyes Stricter Review Guidelines
The alleged deaths were detected by the FDA’s Vaccine Adverse Event Reporting System, reports from which “generally cannot be used to determine” causation or even contribution, according to the agency.
December 1, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Valneva Terminates 30 Amid Site Closure
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
December 1, 2025
·
92 min read
·
BioSpace Editorial Staff
FDA
FDA Delays Decision on Ascendis’ Dwarfism Drug By Three Months
If approved, Ascendis’ TransCon CNP would become the second therapy for achondroplasia, challenging BioMarin’s Voxzogo.
December 1, 2025
·
1 min read
·
Tristan Manalac
Press Releases
FDA Approves IsoPSA® -- Cleveland Diagnostics’ Novel Blood-Based Prostate Cancer Test
December 1, 2025
·
3 min read
Press Releases
Study Reveals Alarming Number of Invasive Breast Cancers in Younger Women
December 1, 2025
·
4 min read
PARTNERED WITH VIVA BIOTECH
Building the Next Generation of Biologics: Inside the Future of Protein Engineering
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new bottleneck: engineering and producing molecules whose complexity challenges conventional workflows.
December 1, 2025
·
9 min read
·
BioSpace Insights
Press Releases
NRG Therapeutics Announces Further Expansion with the Appointment of Paul Thompson as Chief Development Officer
December 1, 2025
·
4 min read
1 of 86,551
Next
